SOPHiA GENETICS (SOPH) Enterprise Value (2021 - 2026)

SOPHiA GENETICS has disclosed Enterprise Value across 6 years of filings, most recently posting $287.5 million for Q2 2026.

• In Q2 2026, Enterprise Value rose 156.91% year-over-year to $287.5 million; the TTM figure through Jun 2026 stood at $287.5 million (up 156.91% YoY), while the FY2025 annual figure was $162.3 million, up 352.63% from the prior year.
• Enterprise Value came in at $287.5 million for Q2 2026 at SOPHiA GENETICS, up from $273.6 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of $287.5 million in Q2 2026 to a low of -$46.3 million in Q4 2022.
• Average Enterprise Value over 5 years is $132.4 million, with a median of $147.6 million recorded in 2024.
• Year-over-year, Enterprise Value sank 107.29% in 2022 and soared 856.63% in 2023.
• Over 5 years, Enterprise Value stood at -$46.3 million in 2022, then soared by 198.92% to $45.8 million in 2023, then retreated by 21.72% to $35.8 million in 2024, then jumped by 352.63% to $162.3 million in 2025, then jumped by 77.19% to $287.5 million in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were $287.5 million in Q2 2026, $273.6 million in Q1 2026, and $162.3 million in Q4 2025.